PulteGroup, Inc. (PHM), one of the largest U.S. homebuilders, has slipped toward the lower end of its 52-week range even as Wall Street price targets remain well above the current share price. The central question for investors is whether PHM can reach $135, a level that implies a meaningful recovery from recent trading levels. This article examines what that target represents, what could support a move toward it, and what stands in the way.
This analysis reviewed 16 current, individually attributed analyst price targets for PHM, ranging from approximately $100 to $166. The arithmetic mean of those targets is about $136, which is rounded to a $135 central target for this article. That figure should not be mistaken for an official published consensus; it is a simple average of the individual targets collected.
The spread of opinion is striking. Bullish firms such as UBS ($166), Evercore ISI ($162), and Wolfe Research ($158) sit far above cautious views from Seaport Global ($100, a Sell rating), Barclays ($110), and RBC Capital ($111). In between, firms including Goldman Sachs ($138), Truist ($136), Melius Research ($132), J.P. Morgan ($130), Morgan Stanley ($128), and Citi ($122) hold more neutral stances. Recent activity has skewed cautious: Barclays and Goldman Sachs lowered their targets in October 2026, while Morgan Stanley initiated coverage at Equal Weight with a $128 target, citing limited upside. Wells Fargo maintained a Buy and a $145 target into mid-October.
At a recent close near $110.90, PHM trades toward the low end of its 52-week range of roughly $107 to $144.50. Reaching the $135 target would require an advance of about 22% — a substantial move, not a marginal one. The stock trades at a forward price-to-earnings (P/E) ratio of roughly 11 times, below the broader market but above its own five-year median, leaving a mixed valuation picture. PulteGroup's earnings have been contracting: 2026 revenue is forecast near $16.3 billion, down from about $17.3 billion in 2025, with earnings per share (EPS) expected to decline to roughly $10 from $11.44. A path to $135 would likely require stabilization in margins and orders, followed by renewed estimate momentum.
Several factors could help PHM toward its price target. The company runs a diversified model spanning entry-level, move-up, and active-adult buyers through brands including Del Webb, which analysts often cite as a differentiator. Its balance sheet is strong, and management has consistently returned capital — buying back shares while paying a modest dividend of roughly $0.26 per quarter (a yield near 0.9%). A stabilization in mortgage rates or improving affordability could reaccelerate order growth, while constrained industry supply has historically supported homebuilder pricing power. Analysts also note that any recovery in 2027 revenue and EPS estimates could justify a higher valuation multiple.
The risks are equally concrete. Elevated mortgage rates and strained affordability continue to weigh on demand, forcing builders to rely on incentives that compress margins. PulteGroup's recent quarters have shown year-over-year declines in closings, pricing, and earnings, and analysts flag the risk of further negative estimate revisions. Barclays specifically cited that risk when lowering its target to $110. A reported federal antitrust probe into homebuilders adds a regulatory overhang, and a broad rotation out of housing-related equities could keep the multiple compressed. If margins deteriorate further or orders disappoint, the low end of the target range could look more relevant than the average.
Technically, PHM sits above a key support level near its 52-week low of roughly $107, an area that has held so far. Below that, the round $100 level coincides with the lowest analyst target and represents a psychological floor. On the upside, the stock would need to clear prior congestion before testing resistance near its 52-week high of about $144.50 — a level just above the central $135 target. The $135 mark itself sits between current prices and that prior peak, meaning the stock would need to traverse a recovery zone without a confirmed breakout catalyst.
Analyst price targets generally reflect a research horizon of around 12 months, though individual assumptions vary. The most immediate catalyst is PHM's third-quarter earnings report on October 22, 2026, before the market opens, along with management's commentary on orders, pricing, and margin trends. Investors should also watch mortgage-rate movements, Federal Reserve policy signals, housing affordability data, and any further analyst target revisions following the report. Regulatory developments tied to the homebuilder antitrust probe could also influence sentiment.
For traders tracking the path of PHM, AI Daily Buy/Sell Signals offer a data-driven way to monitor shifting conditions. The tool uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market dynamics, technical behavior, and AI-driven analysis. Rather than replacing fundamental research, it helps traders surface opportunities, keep an eye on existing positions, and spot emerging trends more efficiently. Explore the AI Daily Buy/Sell Signals to see how AI-based signals can complement your own analysis.
The central $135 target for PHM is a calculated average of 16 analyst price targets spanning $100 to $166, not a guaranteed outcome or an official consensus. It implies a roughly 22% advance from recent levels — a substantial move that would require meaningful improvement in housing demand, margins, and earnings estimates. The bull case rests on a diversified business model, strong capital returns, and a relatively low valuation, while the bear case centers on affordability pressures, declining earnings, and regulatory uncertainty. With third-quarter results imminent and analyst views deeply divided, the report and its guidance will be central to whether the stock can begin closing the gap toward $135.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, PHM has been closely correlated with DHI. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if PHM jumps, then DHI could also see price increases.